[1]
Siripipattanamongkol, C., Srinarong, C. และ Asa, P. 2019. Effectiveness and safety of Pegylated-Interferon/Ribavirin and direct acting antiretroviral: DAA treatment in chronic hepatitis C in Chiangrai Prachanukroh hospital. เชียงรายเวชสาร. 11, 1 (ส.ค. 2019), 41–54.